This qualitative study explores the communication and decision-making strategies of five families with hereditary breast and ovarian cancer (HBOC) risk.Investigators asked female carriers of BRCA1 and BRCA2 genetic mutations to recall early knowledge and experiences concerning cancer risk.Husbands...

Patients with advanced breast cancer are living longer and receiving multiple lines of chemotherapy; however, they eventually develop resistance to the agents. Two more agents have been approved for the treatment of breast cancer and will provide additional treatment options for such patients...

The selection of therapy for women with metastatic breast cancer requires consideration of many factors. Multiple treatment options are available, including hormonal therapy, chemotherapy, and biologic therapy. Many issues exist regarding choice of agent(s), combination therapies, sequencing, and...